Back to All Cases
Product Liability
Talcum Powder Cancer Lawsuits
Individuals diagnosed with ovarian cancer or mesothelioma after using talcum powder products may qualify for compensation. 66,910 cases pending.
Filing Deadline
Filing Now
Settlement Info
66,910 pending cases as of September 2025. J&J bankruptcy attempts rejected - jury trials proceeding.
Overview
Major manufacturers including Johnson & Johnson face thousands of lawsuits from individuals who developed cancer after long-term use of talcum powder products. This is one of the largest mass tort litigations in history.
Key Facts
- Active Cases: 66,910 pending cases as of September 2025
- Total Cases: Over 58,000 as of April 2025
- Defendants: Johnson & Johnson, other manufacturers
- Status: J&J bankruptcy attempts rejected - trials proceeding
Who Qualifies?
You may be eligible if you:
- Used talcum powder products regularly (baby powder, body powder)
- Were diagnosed with ovarian cancer or mesothelioma
- Used products for 10+ years
- Diagnosis occurred after extended use
Scientific Evidence
- 2024 NIH Study: Reinforced link between talc use and ovarian cancer
- Multiple studies show increased cancer risk
- Asbestos contamination found in some talc products
Eligible Diagnoses
- Ovarian cancer (primary condition)
- Mesothelioma (asbestos-related)
- Endometrial cancer (in some cases)
Settlement Potential
- J&J's bankruptcy attempts have been rejected by courts
- Jury trials are proceeding
- Previous verdicts have ranged from millions to billions
- Individual case values depend on diagnosis, usage, and damages
Recent Developments
- September 2025: 66,910 cases pending
- 2024: Courts rejected J&J's bankruptcy strategy
- Ongoing: Trials continue with substantial verdicts
How to File
If you or a loved one developed cancer after using talcum powder, contact us today for a free case evaluation. No upfront costs.
Time May Be Limited
Filing deadlines may apply. Don't wait to find out if you qualify for compensation.
Get Your Free Case Review
Find out if you qualify for compensation. No upfront costs.